Estrogen receptors and the mammary gland;El receptor de estrógenos y la glándula mamaria

Revista de Investigacion Clinica

Volumn 49, Issue 6, 1997, Pages 515-528

  Barrón G, Arturo ^a   Bermejo M, Luisa ^a   Castro R, Ivone ^a,b  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

Author keywords

Breast cancer; Estrogen receptor; Growth factors; Protooncogenes

Indexed keywords

ESTROGEN RECEPTOR;

ANIMAL; BREAST; BREAST TUMOR; EXPERIMENTAL NEOPLASM; FEMALE; HUMAN; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; UDDER;

ANIMALS; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; NEOPLASMS, HORMONE-DEPENDENT; RECEPTORS, ESTROGEN;

EID: 0031264721     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (110)

1. Mueller GC, Herranen AM, Jervel KF. Studies on the mechanism of action of estrogens. Recent Prog Horm Res 1958; 14:93-129.
2. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988; 240:889-93.
3. Krust A, Green S, Argos P, Kumar V, Walter P, Bornet JM, Chambon P. The chicken estrogen receptor sequence: homology to v-erbA and human estrogen and glucocorticoid receptor. EMBO J 1986; 5:891-7.
4. Guichon-Mantel A, Lescop P, Christin-Maitre S, Loosfelt H, Perrot-Applanat M and Milgrom E. Nucleocytoplasmic shuttling of the progesterone receptor. EMBO J 1991; 10:3851-9.
5. Dauvois S, White R, Parker MG. The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci 1993; 106:1377-88.
6. Picard D, Kumar V, Chambon P, Yamamoto KR. Signal transduction by steroid hormones. Nuclear localization is differentially regulated in estrogen and glucocorticoid receptors. Cell Regul 1990; 1:291-9.
7. Ylikomi T, Bocquel MT, Berry M, Gronemeyer H, Chambon P. Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors. EMBO J 1992; 11:1-14.
8. Catelli MG, Binart N, Jung, TI, Renoir JM, Baulieu EE, Feramisco JR, Welch EJ. The common 90-kd protein component of non-transformed "8S" steroid receptors is a heat-shock protein. EMBO J 1985; 4:3131-5.
9. Redeuilh G. Subunit composition of the molybdate stabilised "8-9S" nontransformed estradiol receptor purified from calf uterus. J Biol Chem 1987; 262:6969-75.
10. Pratt WB. Role of heat-shock proteins in steroid receptor function. In steroid hormone action: Parker MG, ed. Oxford: IRL Press; 1993:64-93.
11. Smith DF, Toft DO. Steroid receptors and their associated proteins. Mol Endocrinol 1993; 7:4-11.
12. Chambraud B, Berry M, Redeuuilh G, Chambon P, Baulieu EE. Several regions of the human estrogen receptor are involved in the formation receptor-heat shock protein 90 complexes. J Biol Chem 1990; 265:20686-91.
13. Schlatter LK, Howard JK, Parker MG, Distelhorst CW. Comaparation of the 90-kilodalton heat shock protein interaction with in vitro translated glucocorticoid and estrogen receptors. Mol Endocrinol 1992; 6:132-40.
14. Katzenellenbogen BS, Elliston JF, Monsma FJ, Springer PA, Ziegler YS, Greene GL. Structural analysis of covalently labeled estrogen receptors by limited proteolysis and monoclonal antibody reactivity. Biochemistry 1987; 26:2364-73.
15. Kumar V, Green S, Staub A, Chambon P. Localization of the oestradiol-binding and putative DNA-binding domains of the human estrogen receptor. EMBO J 1986; 5:2231-6.
16. Fawell SE, Lees JA, Parker MG. A proposed consensus steroid-binding sequence - a reply. Mol Endocrinol 1989; 3:1002-5.
17. Danielian PS, White R, Hoare SA, Fawell SE, Parker MG. Identification of residues in the estrogen receptor wich confer differential sensitivity to estrogen and hydrotamoxifen. Mol Endocrinol 1993; 7:232-40.
18. Gorski J, Furlow D, Murdoch F, Fritsch M; Kanero K, Ying C, Malayer J. Perturbations in the model of the estrogen receptor regulation of gene expression.Biol Reprod 1993; 48:8-14.
19. Denton RR, Koszewski NJ, Notides AC. Estrogen receptor phosphorylation: hormonal dependence and consequence on specific DNA binding. J Biol Chem 1992; 267:7263-8.
20. Le Goff P, Montano MM, Schodin DJ, Katzenellenbogen BS. Phosphorylation of the human estrogen receptor: identification of hormone-regulated and examination of their influence on transcriptional activity. J Biol Chem 1994; 269:4458-66.
21. Lahooti H, White R, Danielian PS, Parker MG. Characterization of ligand-dependent phosphorylation of the estrogen receptor. Mol Endocrinol 1994; 8:182-8.
22. Washburn T, Hocutt A, Brautigan DL, Korach KS. Uterine estrogen receptor in vivo: phosphorilation of nuclear specific forms on serine residues. Mol Endocrinol 1991; 5:235-42.
23. Orti E, Bodwell JE, Munck A. Phosphorilation of steroid hormone receptors. Endoc Rev 1992; 13:105-28.
24. Kuiper GGJM, Brinkmann AO. Steroid hormone receptor phosphorylation: is there a physical role? Mol Cell Endocrinol 1994; 100:103-7.
25. Tsai MJ, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 1994; 63:451-86.
26. Ciocca D, Vargas-Roig L. Estrogen receptors in non target tissues: biological and clinical implications. Endocrine Rev 1995; 16:35-62.
27. Dellovade T, Zhu Y, Pfaff D. Potential interactions between estrogen receptor and thyroid receptors relevant for neuroendocrine systems. J Steroid Biochem Mol Biol 1995; 53:27-31.
28. Lachelin GC. Introduction to clinical reproductive endocrinology. London: 1991 Butterwoth-Heinemann.
29. Bergqvist A, Ferno M. Estrogen and progesterone receptors in endometriotic tissue and endometrium: comparison according to localization and recurrence. Fertil Steril 1993; 60:63-8.
30. Howell R, Dowsett M, Edmonds K. Oestrogen and progesterone receptor in endometriosis: heterogenity of different sites. Hum Reprod 1994; 9:1752-8.
31. Kholer M, Berkholz A, Risinger J, Elbendary A, Boyd J, Berchuck A. Mutational analysis of the estrogen-receptor gene in endometrial carcinoma. Obstet Gynecol 1995; 86:33-7.
32. Ma Z, Santagati S, Patrone C, Pollio G, Vegeto E, Maggi A. Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3. Mol Endocrinol 1994; 8:910-8.
33. Van de Vijver M, Nusse R. The molecular biology of breast cancer. Bichem Biophis Acta 1991; 1072:33-50.
34. Clinton G, Rougeot C, Deracourt J, Roger P, Defrene A, Godyna S, et al. Estrogens increase the expression of fibulin-1, an extracellular matrix protein secreted by human ovarian cancer cells. Proc Natl Acad Sci USA 1996; 93:316-20.
35. Ferguson A, Lapidus R, Baylin S, Davidson N. Demethylation of the estrogen receptor gene in estrogen receptor negative breast cancer cell can reactive estrogen receptor gene expresion. Cancer Res 1995; 55:2279-83.
36. Garcia M, Derocq D, Freiss G, Rochefort H. Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. Proc Natl Acad Sci USA 1992; 89:11538-42.
37. Phillips A, Chalbos D, Rochefort H. Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cell without affecting c-fos and c-jun syntesis. J Biol Chem 1993; 268:14103-8.
38. Arbuckle N, Dauvois S, Parker M. Effects of antioestrogens on the DNA binding activity of oestrogen receptors in vitro. Nucleic Acid Res 1992; 20:3839-44.
39. Catherino W, Wolf D, Jordan VC. A naturally occurring estrogen receptor mutation results in increased estrogenicity of a tamoxifen analog. Mol Endocrinol 1995; 9:1053-63.
40. Katzenellenbogen B, Montano M, Le Goff P, Schodin D, Lee Kraus W, Bhardwaj B, et al. Antiestrogens: mechanism and actions in target cells. J Steroid Biochem Mol Biol 1995; 56:387-93.
41. Sumida C, Pasqualini R. Antiestrogens antagonize the stimulatory effect of epidermal growth factor on the induction of progesterone receptor in fetal uterine cells in culture. Endocrinology 1989; 124:591-7.
42. Fuchs-Young R, Glasebrook A, Short L, Draper M, Rippy M, Cole H, et al. Raloxifene is a tissue-selective agonist/ antagonist that functions through the estrogen receptor. Ann New York Acad Sci 1995; 761:355-60.
43. Webb P, Lopez G, Uth R, Kushner P. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell specific estrogen-like effects of antiestrogens. Mol Endocrinol 1995; 9:443-56.
44. McDonnell D, Dana S, Hoener P, Lieberman B, Imhof M, Stein R. Cellular mechanisms which distinguish between hormone- and antihormone-activated estrogen receptor. Ann New York Acad Sci 1995; 761:121-37.
45. Jensen EV, Jacobson HI. Basic guides to the mechanisms of estrogen action. Recent Prog Norm Res 1962; 18:387-414.
46. Gorski J, Toft D, Shyamala G, Smith D, Notides A. Hormone receptors: studies on the interaction of estrogens with the uterus. Recent Prog Horm Res 1968; 24:45-80.
47. Jensen EV, Susuki T, Kawashima T, Stumpf WE, Jungblut PW, DeSombre ER. A two step mechanism for the interaction of estradiol with rat uterus. Proc Natl Acad Sci USA 1968; 59:632-8.
48. Katzenellenbogen B. Dinamics of steroid hormone receptor action. Annu Rev Phisiol 1980; 42:17-25.
49. Landers J, Speisberg T. New concepts in steroid hormone action: transcription factors, protooncogenes, and the cascade model for steroid regulation of gene expression. Crit Rev Eukariot Gene Expr 1992; 2:19-63.
50. Schuchard M, Landers J Punkay N, Spelsberg T. Steroid hormone regulation of nuclear protooncogenes. Endocrine Rev 1993; 14:659-69.
51. Hyder S, Stancel G, Loose-Mitchell D. Steroid hormone-induced expression of oncogene encoded nuclear proteins. Crit Rev Eukariotic Gene Expression 1994; 4:55-116.
52. Bhattacharyya N, Ramsammy R, Eatman E, Hollis V, Anderson W. Protooncogene, growth factor receptor, and estrogen and progesterone receptor gene expression in the inmature rat uterus after treatment with estrogen and tamoxifen. J Submicrosc Cytol Pathol 1994; 26:147-62.
53. Angel P, Karin M. The role of jun, fos and AP1 complex in cell proliferation and transformation. Biochem Biophys Acta 1991; 1072:129.
54. Miner J, Yamamoto K. Regulatory crosstalk at composite elements .TIBS 1991; 16:423-7.
55. Diamond M, Miner J, Yoshiga S, Yamammoto K. Transcription factor interactions: selectors of positive or negative regulation from single DNA elements. Science 1990; 249:1266-72.
56. Jonat C, Rahmsdorf H, Park K, Cato A, Gebel S, Ponta H, et al. Antitumor promotion and antiinflamation: down modulation of AP1 (fos-jun) activity by glucocorticoid hormone. Cell 1990; 62:1189-204.
57. Gaub M, Bellard M, Scheuer Y, Chambon P, Sasson-Corsi P. Activation of ovalbumin gene by the estrogen receptor involves the fos-jun complex. Cell 1990; 63:1267-76.
58. Yang-Yeng H, Chambard J, Sun Y, Smeal T, Schmidt T, Drouin J, et al. Transcriptional interference between c-jun and glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interactions. Cell 1990; 62:1205-15.
59. Travers M, Knowler J. Oestrogen-induced expression of oncogenes in the inmature rat uterus. FEBS Lett 1987; 211:27-30.
60. Murphy L, Murphy L, Friesen H. Estrogen induction of n-myc and c-myc proto-oncogene expression in the rat uterus. Endocrinology 1987; 120:1882-8.
61. Weisz A, Bresciani F. Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus. Mol Endocrinol 1988; 2:816-24.
62. Lau C, Subramaniam M, Rasmussen K Spelsberg T. Rapid inhibition of the c-jun protooncogene expression in avian oviduct by estrogen. Endocrinology 1990; 127:2595-7.
63. Chiappetta C, Stancel G, Loose-Mitchell D. Estrogen-induced regulation of c-jun messenger ribonudeic acid in vivo. J Cell Biol 1990; 109:119a.
64. Van der Burg B, van Selm-Miltenburg A, de Laat S, van Zoelen E. Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells. Mol Cell Endocrinol 1989; 64:223-8.
65. Web D, Moulton B, Khan S. Estrogen induces expression of c-jun and jun-B protooncogenes in specific rat uterine cells. Endocrinology 1993; 133:20-8.
66. Weisz A, Cicatiello L, Persicot E, Scalona M, Bresciani F. Estrogen stimulates transcription of c-jun protooncogene. Mol Endocrinol 1990; 4:1041-50.
67. Persico E, Scalona M, Cicatiello L, Sica V, Bresciani F, Wiesz A. Activation of 'immediate early' gene by estrogen is not sufficient to achieve stimulation of DNA synthesis in rat uterus. Biochem Biophys Res Commun 1990; 171:287-92.
68. Cohrs R, Goswami B, Sharma O. Down regulation of c-myc, c-fos and erb-B during estrogen induced proliferation of three chick oviduct. Biochem Biophys Res Commun 1988; 150:82-8.
69. Hyder S, Stancel G. In vitro interaction of the uterine estrogen receptor with the estrogen response element present in the 3′-flanking region of the murine c-fos protooncogene. J Steroid Biochem Molec Biol 1994; 48:69-79.
70. Loose-Mitchell D, Chiappetta C, Stancel G. Estrogen regulation of c-fos messenger ribonucleic acid. Mol Endocrinol 1988; 2:946-51.
71. Nephew K, Peters G, Khan S. Cellular localization of estradiol induced c-fos messenger ribonucleic acid in the rat uterus: c-fos expression and uterine cell proliferation do not correlate strictly. Endocrinology 1995; 136:3007-15.
72. Nelson K, Takayashi T, Bossert N, Walmer D, McLachan J. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and diferentiation. Proc Natl Acad Sci USA 1991; 88:21-5.
73. Ignar-Trowbridge D, Nelson K, Bidwell M, Curtis S, Washburn T, McLachlan J, et al. Coupling of dual signaling pathways: epidermal growth factor action involves the eslrogen receptor. Proc Natl Acad Sci USA 1992; 89:4658-62.
74. Ignar-Trowbridge D, Teng C, Ross K, Parker M, Korach K, McLachlan J. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Molec Endocrinol 1993; 7:992-8.
75. Chalbos D, Philips A, Rochefort H. Genomic cross-talk between the estrogen receptor and growth factor regulatory pathways in estrogen target tissues. Semin Cancer Biol 1994; 5:361-8.
76. Mouihate A, Lestage J. Estrogen increases the release of epidermal growth factor from individual pituitary cells in female rats. J Endocrinol 1995; 146:495-500.
77. Ignar-Trowbridge D, Pimentel M, Parker M, Mclachlan J, Korach K. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domains and occurs independently of protein kinase C or estradiol. Endocrinology 1996; 137:1735-44.
78. Huynh H, Pollak M. Insulin-like growth factor-I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780. Cancer Res 1993; 53:5585-8.
79. Newton C, Buric R, Trapp T, Brockmeier S, Pagono U, Stalla G. The unligated estrogen receptor (ER) transduces growth factors signals. J Steroid Biochem Molec Biol 1994; 48:481-6.
80. Mukku VR, Stancel G. Regulation of epidermal growth factor receptor by estrogen. J Biol Chem 1985; 260:9820-4.
81. Lingham R, Stancel G, Loose-Mitchell D. Estrogen induction of epidermal growth factor receptor mRNA. Mol Endocrinol 1988; 2:230-5.
82. Murphy LJ, Murphy LC, Friesen HG. Estrogen induces Insulin-like growth factor-1 expression in the rat uterus. Mol Endocrinol 1987; 1:445-50.
83. Tomooka Y, DiAugustine P, Mclachan A. Proliferation of mouse uterine epithelial cells in vitro. Endocrinology 1986; 118:1011-8.
84. Henderson BE, Ross R, Bernstein L. Estrogen as a cause of human cancer. Cancer Res 1988; 48:246-53,
85. Marchant DJ. Risk factors. Obstet Gynecol Clin North Am 1994; 21:561-86.
86. Thomas DB. Do hormones cause breast cancer? Cancer 1984; 53:595-604.
87. Henderson BE, Ross RK, Pike MC, Casagrande JT. Endogenous hormones as a major factor in human cancer. Cancer Res 1982; 43:3232-9.
88. Zajchowski DA, Sager R, Webster L Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Res 1993; 53:5004-11.
89. van Agthoven T, van Agthoven TLA, Foekens JA, Dorssers LCJ. Regulation of gene expression involved in the progression of human breast cancer to hormone independence. Ann New York Acad Sci 1993; 684:250-2.
90. Osborne CK, Yochmowitz MG, Knight III WA, McGuire WL. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 1980; 46:2884-8.
91. Petersen OW, Hoyer PE, van Deurs B. Frecuency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. Cancer Res 1987; 47:5748-51.
92. Jacquemier JD, Hassouin J, Torrente M, Martin PM. Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lessions at various stages-immunohistochemical study of 107 cases. Breast Cancer Res Treat 1990; 15:109-17.
93. Wittliff JL. Steroid-hormone receptors in breast cancer. Cancer 1984; 53:630-43.
94. McGuire WL, Chamness GC, Fuqua SAW. Estrogen receptor variants in clinical breast cancer. Mol Endocrinol 1991; 5:1571-7.
95. Santen R, Manni A, Harvey H, Redmond C. Endocrine treatment of breast cancer in women. Endocrine Rev 1990; 11:221-65.
96. Ricketts D, Turnbull L, Ryall G, Bakhshi R, Rawson NSB, Gazet JC, et al. Estrogen and progesterone receptors in the normal female breast Cancer Res 1991; 51:1817-22.
97. deConinck EC, McPherson LA, Weigel RJ. Transcriptional regulation of estrogen receptor in breast carcinomas. Mol Cel Biol 1995; 15:2191-6.
98. Fuqua SAW, Chamness GC, McGuire WL Estrogen receptor mutations in breast cancer. J Cell Biochem 1993; 51:135-9.
99. Fuqua SAW, Fitzgerald SD, Allred DC, Elledge RM, Nawas Z, McDonnell DP, et al. Inhibition of estrogen receptor action by a naturally occuring variant in human breast tumors. Cancer Res 1992; 52:483-6.
100. Herskowitz I. Functional inactivation of genes by dominant negative mutations.Nature 1987; 29:219-22.
101. Ince BA, Schodin DJ, Shapiro DJ, Katzenellenbogen BS. Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptors. Endocrinology 1995; 136:3194-9.
102. Weigel RJ, deConinck EC. Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma. Cancer Res 1993; 53:3472-4.
103. Ottaviano YL, Issa JP, Parl FF, Smith HS, Baylin SB, Davidson NE. Methylation of the estrogen receptor gene CpG island marks loss of the estrogen receptor expression in human breast cancer cells. Cancer Res 1994; 54:2552-5.
104. Bird AP. CpG-rich islands and function of DNA methylation. Nature 1986; 321:209-13.
105. Li E, Beard C, Jeanisch R. Role for DNA methylation in genomic imprinting. Nature 1993; 366:362-5.
106. van Agthoven T, van Agthoven TLA, Portengen H, Foekens JA, Dorssers LCJ. Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells. Cancer Res 1992; 52:5082-8.
107. Safarians S, Sternlicht MD, Yamanishi DT, Love SM, Barsky SH. Human breast cancer progression can be regulated by dominant trans-acting factors in somatic cell hibridization studies. Cancer Res 1996; 56:3560-9.
108. Jiang SY, Jordan VC. Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J Natl Cancer Inst 1992; 84:580-91.
109. Zajchowski DA, Sager R. Induction of estrogen-regulated genes differs in immortal and tumorigenic human mammary epithelial cells expressing a recombinant estrogen receptor. Mol Endocrinol 1991; 5:1613-23.
110. Smith E, Boyd J, Frank G, Takahashi H, Cohen R, Specker B, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in man. N Engl J Med 1994; 331:1056-61.